Pemetrexed dipotassium

Pemetrexed dipotassium is a chemotherapy drug used mainly to treat certain cancers including non-small cell lung cancer and malignant pleural mesothelioma. It is a folate analog metabolic inhibitor that disrupts folate-dependent processes essential for cancer cell replication by inhibiting enzymes like thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase, thereby impeding DNA and RNA synthesis in cancer cells. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pemetrexed dipotassium salt. Its PubChem CID is 136266586.

CAS No 1438895-00-1
Molecular Formula C20H19K2N5O6
Molecular Weight 503.6 g/mol
Synonyms dipotassium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate

Frequently Asked Questions